Byotrol plc
("Byotrol", the "Company" or the "Group")
Result of AGM
The Company is pleased to announce that at its AGM held earlier today, all resolutions put to the AGM were duly passed.
Enquiries:
David Traynor - Chief Executive, Byotrol plc 01925 742 000
David Paton - Investor Relations 07714 190 474
finnCap Ltd 020 7220 0500 (Nominated Adviser & Broker)
Geoff Nash/Kate Bannatyne - Corporate Finance
Richard Chambers - Corporate Broking
Notes to Editors:
Byotrol plc (BYOT.L), quoted on AIM, is a specialist developer of antimicrobial technologies, identifying, developing, formulating and commercialising cutting-edge antimicrobial solutions.
Our patented suite of technologies deliver powerful, broad-spectrum efficacy, optimised against commonly-occurring and industry-specific pathogens.
Founded in 2005, the Company seeks to develop and commercialise advanced antimicrobial technologies that create easier, safer and cleaner lives for everyone.
For more information, please go to www.byotrol.co.uk